Kamel I - Search Results

1

Impact of a single-day multidisciplinary clinic on the management of patients with liver tumours.

Zhang J, Mavros MN, Cosgrove D, Hirose K, Herman JM, Smallwood-Massey S, Kamel I, Gurakar A, Anders R, Cameron A, Geschwind JF, Pawlik TM. Zhang J, et al. Among authors: kamel i. Curr Oncol. 2013 Apr;20(2):e123-31. doi: 10.3747/co.20.1297. Curr Oncol. 2013. PMID: 23559879 Free PMC article.

2

Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma.

Kamel IR, Bluemke DA, Ramsey D, Abusedera M, Torbenson M, Eng J, Szarf G, Geschwind JF. Kamel IR, et al. AJR Am J Roentgenol. 2003 Sep;181(3):708-10. doi: 10.2214/ajr.181.3.1810708. AJR Am J Roentgenol. 2003. PMID: 12933464 No abstract available.

3

Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution.

Burger I, Hong K, Schulick R, Georgiades C, Thuluvath P, Choti M, Kamel I, Geschwind JF. Burger I, et al. Among authors: kamel i. J Vasc Interv Radiol. 2005 Mar;16(3):353-61. doi: 10.1097/01.RVI.0000143768.60751.78. J Vasc Interv Radiol. 2005. PMID: 15758131

4

The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.

Kamel IR, Bluemke DA, Eng J, Liapi E, Messersmith W, Reyes DK, Geschwind JF. Kamel IR, et al. J Vasc Interv Radiol. 2006 Mar;17(3):505-12. doi: 10.1097/01.RVI.0000200052.02183.92. J Vasc Interv Radiol. 2006. PMID: 16567675

5

Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States.

Dorfman JD, Schulick R, Choti MA, Geschwind JF, Kamel I, Torbenson M, Thuluvath PJ. Dorfman JD, et al. Among authors: kamel i. World J Gastroenterol. 2007 Feb 7;13(5):781-4. doi: 10.3748/wjg.v13.i5.781. World J Gastroenterol. 2007. PMID: 17278203 Free PMC article.

6

Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma.

Kamel IR, Reyes DK, Liapi E, Bluemke DA, Geschwind JF. Kamel IR, et al. J Vasc Interv Radiol. 2007 Jan;18(1 Pt 1):49-56. doi: 10.1016/j.jvir.2006.10.005. J Vasc Interv Radiol. 2007. PMID: 17296704

7

Biopsy considerations in the diagnosis of hepatic masses.

Anders RA, Kamel IR. Anders RA, et al. Clin Gastroenterol Hepatol. 2007 May;5(5):541-4. doi: 10.1016/j.cgh.2007.02.028. Clin Gastroenterol Hepatol. 2007. PMID: 17478344 Review.

8

Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.

Buijs M, Kamel IR, Vossen JA, Georgiades CS, Hong K, Geschwind JF. Buijs M, et al. J Vasc Interv Radiol. 2007 Aug;18(8):957-63. doi: 10.1016/j.jvir.2007.04.025. J Vasc Interv Radiol. 2007. PMID: 17675611

9

Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization.

Liapi E, Geschwind JF, Vossen JA, Buijs M, Georgiades CS, Bluemke DA, Kamel IR. Liapi E, et al. AJR Am J Roentgenol. 2008 Jan;190(1):67-73. doi: 10.2214/ajr.07.2550. AJR Am J Roentgenol. 2008. PMID: 18094295

10

Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization.

Vossen JA, Kamel IR, Buijs M, Liapi E, Georgiades CS, Hong K, Geschwind JF. Vossen JA, et al. J Comput Assist Tomogr. 2008 May-Jun;32(3):347-52. doi: 10.1097/RCT.0b013e318134ecd6. J Comput Assist Tomogr. 2008. PMID: 18520535

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

531 results

Search Page

Filters